Shizuoka, Japan

Yasuhiro Okamoto

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Okamoto. Retrieved from https://idiyas.com/inventor/yasuhiro-okamoto-8acw0be2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuhiro Okamoto: Innovator in Pharmaceutical Composition

Introduction

Yasuhiro Okamoto is a notable inventor based in Shizuoka-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of pharmaceutical compositions.

Latest Patents

Yasuhiro Okamoto holds a patent for an acylated cyclodextrin-containing pharmaceutical composition. This composition is designed for trans-mucosal or transdermal administration, utilizing a per-C.sub.2-18 acylated cyclodextrin as a drug reservoir or carrier. The formulation is recognized for its safety and excellent drug release behavior, making it a valuable advancement in pharmaceutical technology.

Career Highlights

Okamoto is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role involves research and development, where he applies his expertise to create innovative solutions for drug delivery.

Collaborations

Throughout his career, Yasuhiro Okamoto has collaborated with esteemed colleagues, including Kaneto Uekama and Fumitoshi Hirayama. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Yasuhiro Okamoto's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving drug delivery systems. His work continues to influence the field and offers promising solutions for future pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…